Reliant Investment Management LLC Cuts Holdings in Procter & Gamble Company (The) $PG

Reliant Investment Management LLC lowered its stake in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 2.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,473 shares of the company’s stock after selling 240 shares during the period. Reliant Investment Management LLC’s holdings in Procter & Gamble were worth $1,828,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. MOKAN Wealth Management Inc. boosted its position in Procter & Gamble by 13.7% during the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock valued at $2,442,000 after purchasing an additional 1,846 shares in the last quarter. Benjamin Edwards Inc. lifted its position in shares of Procter & Gamble by 120.7% during the first quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock valued at $62,098,000 after buying an additional 199,258 shares during the last quarter. Capital Investment Advisory Services LLC boosted its holdings in shares of Procter & Gamble by 13.8% in the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock valued at $6,426,000 after buying an additional 4,562 shares in the last quarter. World Investment Advisors grew its position in shares of Procter & Gamble by 6.0% in the 1st quarter. World Investment Advisors now owns 50,913 shares of the company’s stock worth $8,677,000 after buying an additional 2,886 shares during the last quarter. Finally, Concurrent Investment Advisors LLC raised its stake in shares of Procter & Gamble by 26.4% during the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company’s stock worth $20,451,000 after acquiring an additional 25,059 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Stock Performance

Shares of PG opened at $152.12 on Thursday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The stock has a 50-day moving average of $154.73 and a two-hundred day moving average of $158.50. The stock has a market cap of $356.03 billion, a P/E ratio of 23.37, a P/E/G ratio of 4.02 and a beta of 0.36. Procter & Gamble Company has a one year low of $146.96 and a one year high of $180.43.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period last year, the business posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be paid a $1.0568 dividend. The ex-dividend date is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble’s dividend payout ratio is presently 64.98%.

Insider Activity

In other news, CEO Gary A. Coombe sold 10,194 shares of the business’s stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares of the company’s stock, valued at $5,532,120.48. The trade was a 22.57% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Shailesh Jejurikar sold 13,039 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $2,050,643.53. Following the sale, the chief operating officer directly owned 28,036 shares in the company, valued at approximately $4,409,221.72. This trade represents a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock valued at $23,421,279 over the last quarter. Insiders own 0.20% of the company’s stock.

Analyst Upgrades and Downgrades

PG has been the subject of several recent analyst reports. Raymond James Financial lowered their target price on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a research note on Monday. BNP Paribas Exane lowered their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. Barclays reduced their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. JPMorgan Chase & Co. lowered their price target on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a report on Friday, October 10th. Finally, Berenberg Bank upped their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $171.68.

Read Our Latest Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.